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ABSTRACT
Human immunodeficiency virus (HIV) is most commonly
transmitted by sexual activity. HIV is found in blood and other
body fluids, including semen, vaginal fluid and saliva. Spread
of the HIV from oral secretions of the millions of HIV viremic
individuals, during kissing, dental treatment, biting is a very
uncommon finding. The shedding of infected blood or exudates
from the saliva of an infected individual usually contains only
the noninfectious component of HIV and may also contain
fragments or the entire noninfectious genome. The risk of HIV
transmission via oral secretions is an issue of growing interest
to the dental health professionals. The oral transmission of HIV
remains a controversial issue and a cause of concern.
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INTRODUCTION
Human immunodeficiency virus (HIV) is most commonly
transmitted by sexual activity. HIV is found in blood and
other body fluids, including semen, vaginal fluid and saliva.
Spread of the HIV from oral secretions of the millions of
HIV viremic individuals, during kissing, dental treatment,
biting is a very uncommon finding. Scully and Porter 1991
have reported only three cases of occupational transmission
of HIV affecting two dentists and a dental assistant.
The shedding of infected blood or exudates from the
saliva of an infected individual usually contains only the
noninfectious component of HIV and may also contain
fragments or the entire noninfectious genome. Only 1 to
5% of patient’s saliva contains infectious HIV although they
all carry viruses in their blood. Most of the HIV shed at any
mucosal site/surface during the asymptomatic infection
originates from infected mononuclear leukocytes.5 Viruses
present in the body are neutralized by the antibodies
produced after the initial acute infection.
The combined action of role of endogenous salivary anti-
viral factors such as lysozymes, defensins, secretory
leukocyte protease inhibitors, all act by inhibitory binding
between HIV and CD4+ lymphocytes. A new potent salivary
inhibitor identified as the unique hypotonicity of saliva is
said to have anti-HIV action.
The risk of HIV transmission via oral secretions is an
issue of growing interest to the dental health professionals.
The oral transmission of HIV remains a controversial issue
and a cause of concern.
DISCUSSION
The oral mucosa is a stratified squamous epithelium
supported by lamina propria. Unlike other mucosal sites
oral cavity is rarely a site of HIV transmission. The mucosal
compartmentalized mucosa-associated lymphoid tissue
(MALT).9
Archibald et al8 (1992) reported only 1% incidence of
infected saliva in HIV carriers, although all carriers have
infectious virus in their blood. The rarity of casual oral
transmission is easy to correlate with the incidence of high
vaginal (27%) and high infectivity in the seminal fluid
transmission.
Cohen MS et al (2000),4 in their study reported that HIV
transmission from saliva or intimate family contact is
extremely rare, and this could be attributed to low
concentration of HIV-1 in saliva.
WHAT ANTI-HIV BARRIERS DOES THE ORAL
CAVITY HAVE? WHAT IS THEIR ROLE?
HIV shows favorability for CD4+ receptors in the cell
membrane of monocytes and lymphocytes. The most
common cell type in the oral cavity is the epithelial cell; a
cell type which does not express the CD4 antigen hence is
not prone to infection. (Milman and Sharma, 1994).3
Baron S (2001)3 states that most of the HIV infectivity
in carrier’s secretions and blood occurs as infected
leukocytes rather than as cell-free HIV.
Lamm (1977)10 also reported that human epithelial cells
could be infected by HIV and transfer the infection to
adjacent leukocytes, where these get neutralized by IgA.
Also the transcytosis of HIV via epithelial cells can be
inhibited by S-IgA, IgG or IgM. The very low presence of
HIV-infected epithelial cells in the oral cavity indicates that
oral mucosal cells contribute minimally to the viral load in
saliva. Any free infectious HIV in mucosal secretions will
have low affinity for mucosal epithelial cells of the mouth,
esophagus, vagina and rectum because these cells lack the
CD4 receptor for free HIV to bind.
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The frequency and infectivity of saliva and the oral
mucosal cells is reported to be lower than that in other
secretions (Baron et al 1999).2 The frequency of HIV antigen
detection has ranged from 0 to 35% and that of proviral
DNA and viral RNA detection from 12 to 100% (Yeung et
al 1993).11 Another study by Tamashiro and Constantine
(1994)7 reported that the immunoglobulin content of oral
fluids is similar to that of blood, but their levels are less.
However, the use of an HIV IgG antibody capture assay
(GAC ELISA) designed specifically for testing oral fluids,
and certain routine HIV blood tests can produce encouraging
results. Viral cultures from saliva have shown HIV titers in
only 0 to 39% cases (Gropman et al 1984).12 Hence literature
states that the saliva of a large proportion of HIV patients
does not contain the virus.
A healthy and intact mucosa forms an excellent barrier
against infection by pathogenic microorganisms including
viruses. The lubricating action of the mucosal surface, low
number of CD4+ cells and the diluting action of saliva
dilutes the microbial load and expels microorganisms toward
the gastrointestinal tract for their inactivation and
destruction. A thick epithelial layer and presence of antiviral
antibodies and various endogenous factors also act for the
inhibitory action of oral mucosa.5 Saliva’s army for inhibitory
HIV transmission consists of HIV-1-specific antibodies,
lyzozymes, peroxidases, Clq component of complement,
cystatins, lactoferrin, defensins, mucins, amylase, statherins,
proline-rich peptide, thrombospondin-1, histatins and
secretory leukocyte protease inhibitor, ribonuclease1
(Table 1).
SALIVA’S HYPOTONICITY KILLS CELLS AND
THEREBY PREVENTS VIRUS MULTIPLICATION
Baron et al (2001)3 reported a new potent salivary inhibitor
of HIV transmission, unique hypotonicity of saliva. Saliva
Fig. 1: Disruption of human mononuclear leukocytes incubated
at 34°C for 15 minutes with saliva compared with blood plasma
Table 1: Salivary factors with anti-HIV activity1
Factors HIV-inhibitory mechanism
Anti-HIV antibodies Neutralize and inactivate the virus IgA. Inhibits interaction between gp120
and CD4
Clq component of complement In presence of fibronectin, binds to the virus and produces its sedimentation
Cystatins Have general antimicrobial activity: Inhibit cysteine proteases
Defensins (, o defensins and mini-defensins) Have general antimicrobial activity: Block penetration by the virus
Lactoferrin Binds to iron to inhibit bacterial proliferation and viral replication
Lactoperoxidase Inactivates virus by production of thiocyanate
Lysozyme Interrupts HIV replication by destroying viral membranes
Ribonuclease Blocks the reproduction of the virus by destroying its genetic material
(metabolize select RNA)
Mucins Sequester and aggregate viral particles
Secretory leukocyte protease inhibitor (SLPI) Interact with a cellular surface molecule to limit viral entry into target cells
Thrombospondin 1 (TSP-1) Produces aggregation of the virus; during penetration by the virus, blocks its
interactions with lymphocytes
Proline-rich proteins (PRPs) Bind to gp120 of the virus, preventing its penetration of lymphocytes
Salivary agglutinins (SAG) Bind to gp120 from virions, agglutinate HIV and dissociate viral envelope
proteins
has the ability to rapidly disrupt (>90%) mononuclear
leukocytes (Fig. 1).2 It is estimated that complete cell
disruption and the resulting interruption of virus
multiplication occurs with solutions containing the same
low-salt concentration as saliva. Extreme hypotonicity, as
in saliva causes cell death by osmotic swelling and bursting
of cells and their plasma membrane.
Baron et al (1999)2 also reported salivary hypotonicity
appears to destroy the cell wall of HIV-infected mononuclear
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For health care workers, oral transmission of HIV is of
prime concern and may be increased under special
conditions, such as:
• Acute HIV infection where cell-free HIV is high.
• Advanced acquired immunodeficiency syndrome where
cell-associated HIV is high.6
• Oral sex, where the seminal fluid protects the infected
cells against saliva.
• Saline irrigation of the mouth that may overcome the
hypotinicity of saliva and create aerosols.
• Cofactors, such as oral ulcers, gingival bleeding
(gingivitis or periodontitis) or the presence of other
infections in the oral cavity.
CONCLUSION
Taken together the present findings indicate that the rarity
of transmission of HIV from the oral cavity may be not
only due to the reported nonspecific salivary inhibitors but
also largely due to hypotonic saliva-induced disruption of
infected cells. Hypotonic disruption may be a major
mechanism by which saliva kills infected mononuclear
leukocytes and prevents their attachment to mucosal
epithelial cells and production of infectious HIV, thereby
preventing transmission. The conclusion is based on the
limited inhibition of HIV by the reported salivary inhibitors
(2 to 5-fold) compared with the 10,000-fold or higher
inhibition by salivary lysis of infected leukocytes.2 Indeed,
transmission of HIV through oral cavity is a rarity.
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Table 2: HIV-inhibitory activity of different body fluids
Mucosal fluid Relative inhibitory
activity
Colostrum High (78.5)
Whole saliva High (72.5)
Maternal milk (postcolostrum) High (68.9)
Cervicogingival secretions Moderate (51.2)
Sublingual and submandibular saliva Moderate (38.8)
Seminal plasma Moderate (36.7)
Parotid saliva Low (13.6)
leukocytes, preventing them from binding to mucosal
epithelial cells and producing infective HIV. Complete
inhibition of virus yield occurred with mixtures of solutions
containing 100 and 75% saliva, implying the killing of
infected cells by saliva. While diminished inhibition of virus
yield was reported with mixtures containing 75 to 25%
saliva, implying partial killing of cells by saliva.
Hence, the demonstrated killing of HIV-infected
leukocytes by the hypotonicity of saliva would prevent all
routes of transmission, namely attachment to epithelial cells,
penetration of the epithelium by infected mononuclear
leukocytes and virus production. The effect of hypotonicity
on any shed infectious cell-free HIV by hypotonic solutions
like water and perhaps saliva may occur over hours,
compared to immediate lysis of infected cells.
HIV INHIBITORY ACTIVITY OF OTHER
BODY FLUIDS
Fultz (1986) published the first study to report that the whole
saliva of chimpanzees and humans protect cells susceptible
to HIV infection in vitro. The other body fluids with an
anti-HIV activity are shown in Table 2.
SPECIAL CONDITIONS IN WHICH ORAL
TRANSMISSION MAY OCCUR
The inhibition is offset by isotonic secretions such as breast
milk and semen. Orally deposited seminal fluid, milk or
colostrum reverses the ability of saliva to inactivate virus-
infected leukocytes by the reconstitution of salts and solutes
in hypotonic saliva. The hypotonic disruption is a major
mechanism by which saliva inactivates transmitting
leukocytes and prevents their attachment to mucosal
epithelial cells. This accounts for the paradox of successful
oral transmission by the seminal fluid and milk. Hypotonic
lysis of shed-infected leukocytes can be overcomed by
unusually large volumes of isotonic fluids in the mouth thus
leading to oral transmission of HIV. Such rare conditions
could be:
• Isotonic blood in the mouth- as may be in the case of oral
transmission by the bite of patient who was experiencing
heavy bleeding in the mouth (Lancet 1987).13
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